ELTX
Price
$14.20
Change
+$0.65 (+4.80%)
Updated
Jun 9 closing price
Capitalization
271.02M
58 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$29.05
Change
+$0.56 (+1.97%)
Updated
Jun 9 closing price
Capitalization
20.89B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELTX vs ROIV

Header iconELTX vs ROIV Comparison
Open Charts ELTX vs ROIVBanner chart's image
ELTX vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
ELTX vs. ROIV commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELTX is a StrongBuy and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2026
Stock price -- (ELTX: $14.20 vs. ROIV: $29.05)
Brand notoriety: ELTX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELTX: 94% vs. ROIV: 62%
Market capitalization -- ELTX: $271.02M vs. ROIV: $20.89B
ELTX [@Biotechnology] is valued at $271.02M. ROIV’s [@Biotechnology] market capitalization is $20.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELTX’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • ELTX’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than ELTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELTX’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • ELTX’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ELTX and ROIV are a good buy in the short-term.

Price Growth

ELTX (@Biotechnology) experienced а +23.59% price change this week, while ROIV (@Biotechnology) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -7.17%, and the average quarterly price growth was -4.06%.

Reported Earning Dates

ELTX is expected to report earnings on Aug 07, 2026.

ROIV is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($20.9B) has a higher market cap than ELTX($271M). ELTX has higher P/E ratio than ROIV: ELTX (5.96) vs ROIV (1.97). ELTX YTD gains are higher at: 78.392 vs. ROIV (33.848). ELTX has higher annual earnings (EBITDA): -37.68M vs. ROIV (-1.28B). ROIV has more cash in the bank: 4.29B vs. ELTX (14.9M). ELTX has less debt than ROIV: ELTX (14.3M) vs ROIV (107M). ROIV has higher revenues than ELTX: ROIV (8.26M) vs ELTX (0).
ELTXROIVELTX / ROIV
Capitalization271M20.9B1%
EBITDA-37.68M-1.28B3%
Gain YTD78.39233.848232%
P/E Ratio5.961.97303%
Revenue08.26M-
Total Cash14.9M4.29B0%
Total Debt14.3M107M13%
TECHNICAL ANALYSIS
Technical Analysis
ELTXROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 23 days ago
86%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ELTX
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD6.270.55
+9.62%
Relmada Therapeutics
AER139.023.31
+2.44%
Aercap Holdings NV
ALOT15.700.02
+0.16%
AstroNova
ASO50.41-1.26
-2.44%
Academy Sports and Outdoors
CANF2.91-0.17
-5.52%
Can-Fite Biopharma Ltd

ELTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELTX has been loosely correlated with PRME. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ELTX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
+4.80%
PRME - ELTX
36%
Loosely correlated
-2.97%
JANX - ELTX
35%
Loosely correlated
+0.81%
NKTX - ELTX
32%
Poorly correlated
+1.25%
ROIV - ELTX
31%
Poorly correlated
+1.95%
CLYM - ELTX
31%
Poorly correlated
+3.34%
More